These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8393797)

  • 1. Induction of protective immunity against coronavirus-induced encephalomyelitis: evidence for an important role of CD8+ T cells in vivo.
    Flory E; Pfleiderer M; Stühler A; Wege H
    Eur J Immunol; 1993 Aug; 23(8):1757-61. PubMed ID: 8393797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant vaccinia viruses which express MHV-JHM proteins: protective immune response and the influence of vaccination on coronavirus-induced encephalomyelitis.
    Flory E; Stühler A; Wege H; Siddell S; Wege H
    Adv Exp Med Biol; 1993; 342():401-6. PubMed ID: 8209761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S.
    Flory E; Stühler A; Barac-Latas V; Lassmann H; Wege H
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():873-9. PubMed ID: 9049333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunodominant CD4+ T cell site on the nucleocapsid protein of murine coronavirus contributes to protection against encephalomyelitis.
    Wege H; Schliephake A; Körner H; Flory E; Wege H
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1287-94. PubMed ID: 8393072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells.
    Körner H; Schliephake A; Winter J; Zimprich F; Lassmann H; Sedgwick J; Siddell S; Wege H
    J Immunol; 1991 Oct; 147(7):2317-23. PubMed ID: 1655890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus induced encephalomyelitis: an immunodominant CD4(+)-T cell site on the nucleocapsid protein contributes to protection.
    Wege H; Schliephake A; Körner H; Flory E; Wege H
    Adv Exp Med Biol; 1993; 342():413-8. PubMed ID: 7911644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
    Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
    J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal humoral immune response in coronavirus induced encephalomyelitis of Lewis and BN rats.
    Dörries R; Watanabe R; Wege H; ter Meulen V
    Adv Exp Med Biol; 1987; 218():373-81. PubMed ID: 2829548
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
    Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW
    J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of mice to murine coronavirus immunization.
    Smith AL; de Souza MS; Finzi D; Barthold SW
    Arch Virol; 1992; 125(1-4):39-52. PubMed ID: 1322658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus strain specificity of challenge immunity to coronavirus.
    Barthold SW; Smith AL
    Arch Virol; 1989; 104(3-4):187-96. PubMed ID: 2468325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus-induced demyelination occurs in the presence of virus-specific cytotoxic T cells.
    Castro RF; Evans GD; Jaszewski A; Perlman S
    Virology; 1994 May; 200(2):733-43. PubMed ID: 8178457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immunity against vaccinia virus infection of mice.
    Xu R; Johnson AJ; Liggitt D; Bevan MJ
    J Immunol; 2004 May; 172(10):6265-71. PubMed ID: 15128815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
    Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody.
    Perlman S; Schelper R; Bolger E; Ries D
    Microb Pathog; 1987 Mar; 2(3):185-94. PubMed ID: 2853274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
    Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
    J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens: antibody-response inhibition induced by immunization with a mixture of recombinants differing in virulence.
    Kutinová L; Ludvíková V; Marešová L; Němečková Š; Brouček J; Hainz P; Vonka V
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2901-2908. PubMed ID: 10580051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
    Connors M; Kulkarni AB; Collins PL; Firestone CY; Holmes KL; Morse HC; Murphy BR
    J Virol; 1992 Feb; 66(2):1277-81. PubMed ID: 1731105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
    Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F
    Eur J Immunol; 1988 Dec; 18(12):1917-24. PubMed ID: 2905993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.